ARCHIVES

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

NIH Funding Opportunity: Outstanding Investigator Award In Cancer Research Available

June 11, 2014

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996

FDA Approves Arranon For Leukemia And Lymphoma

December 30, 2005

Brown Needs Decision By March 31; Sander Decline HEW Offer

March 4, 1977

Varmus: Plan Would Give Trials A Strong Scientific Base

December 17, 2010

Cancer Mortality By County For 1950-69 Now Available From GPO; Price-$9

April 26, 1974